Evaluating the safety and efficacy of axitinib in the treatment of advanced renal cell carcinoma
Orvar Gunnarsson,1 Nicklas R Pfanzelter,2 Roger B Cohen,1 Stephen M Keefe1 1Department of Medicine, Division of Hematology and Oncology, Hospital of the University of Pennsylvania, Philadelphia, PA, 2Department of Medicine, Division of Hematology and Oncology, Rush University Medical Center, Chicag...
Main Authors: | Gunnarsson O, Pfanzelter NR, Cohen RB, Keefe SM |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-02-01
|
Series: | Cancer Management and Research |
Online Access: | http://www.dovepress.com/evaluating-the-safety-and-efficacy-of-axitinib-in-the-treatment-of-adv-peer-reviewed-article-CMAR |
Similar Items
-
Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma
by: Marine Gross-Goupil, et al.
Published: (2013-01-01) -
Axitinib: A Review of its Safety and Efficacy in the Treatment of Adults with Advanced Renal Cell Carcinoma
by: Marine Gross-Goupil, et al.
Published: (2013-10-01) -
Critical appraisal of axitinib in the treatment of advanced renal cell carcinoma
by: Ansari J, et al.
Published: (2013-02-01) -
Targeted treatments in advanced renal cell carcinoma: focus on axitinib
by: Verzoni E, et al.
Published: (2014-03-01) -
Axitinib in the treatment of renal cell carcinoma: patient selection and perspectives
by: Narayan V, et al.
Published: (2016-03-01)